Nintedanib Reduces Ventilation-Augmented Bleomycin-Induced Epithelial-Mesenchymal Transition And Pulmonary Fibrosis Through Suppressing The Src Pathway

Li-Fu Li

Nintedanib Reduces Ventilation-Augmented Bleomycin-Induced Epithelial-Mesenchymal Transition And Pulmonary Fibrosis Through Suppressing The Src Pathway

Li-Fu Li

臨床醫學研究所(含碩博士班)

研究成果: 期刊稿件 › 文章 › 同行評審

原文	美式英語
期刊	American Journal of Respiratory and Critical Care Medicine
卷	195
出版狀態	已出版 - 2017

引用此

@article{5799bb116030403396960031ae6aa8a9,

title = "Nintedanib Reduces Ventilation-Augmented Bleomycin-Induced Epithelial-Mesenchymal Transition And Pulmonary Fibrosis Through Suppressing The Src Pathway",

author = "Li-Fu Li",

year = "2017",

language = "American English",

volume = "195",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

}

TY - JOUR

T1 - Nintedanib Reduces Ventilation-Augmented Bleomycin-Induced Epithelial-Mesenchymal Transition And Pulmonary Fibrosis Through Suppressing The Src Pathway

AU - Li, Li-Fu

PY - 2017

Y1 - 2017

M3 - Journal Article

SN - 1073-449X

VL - 195

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

ER -